Profile data is unavailable for this security.
About the company
Sisram Medical Ltd. is an Israel-based company primarily engaged in the medical aesthetics industry. The Company focuses on developing and manufacturing natural energy-based medical aesthetic devices and dental equipment. The Company operates several brands among which are Alma, LMNT, Copulla. Alma is provider of energy-based solutions for surgical, medical aesthetics, and beauty markets. It offers a range of products for hair removal, skin rejuvenation, acne treatment, body and face contouring, and more; LMNT, a personal care brand that delivers wellness into daily routines. It focuses on providing consumers with special purpose technology for personal care; Copulla, which offers an end-to-end digital dentistry service that aims to streamline the dental workflow and to cover all aspects from intra-oral scanning to the final delivery of dental appliances.
- Revenue in HKD (TTM)2.70bn
- Net income in HKD160.77m
- Incorporated2013
- Employees1.04k
- LocationSisram Medical LtdOFEK 15 Building18 HaHarash Street, Industrial ParkCAESAREA 3079895IsraelISR
- Phone+972 46275357
- Websitehttps://sisram-medical.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Kaisa Health Group Holdings Ltd | 166.42m | -31.22m | 968.09m | 917.00 | -- | 2.22 | -- | 5.82 | -0.0062 | -0.0062 | 0.033 | 0.0865 | 0.308 | 6.69 | 1.52 | 193,284.50 | -6.59 | -7.25 | -7.83 | -9.34 | 41.58 | 45.27 | -21.40 | -28.20 | 3.89 | -- | 0.0257 | -- | -0.2824 | -5.93 | -720.72 | -- | -19.69 | -- |
| Gaush Meditech Ltd | 1.63bn | 115.25m | 976.06m | 819.00 | 8.42 | 0.5098 | 4.72 | 0.5995 | 0.7838 | 0.7838 | 11.09 | 12.95 | 0.535 | 2.08 | 9.05 | 1,841,819.00 | 3.62 | -1.53 | 4.67 | -2.20 | 47.29 | 47.66 | 6.77 | -2.90 | 1.57 | 8.16 | 0.2188 | -- | 1.58 | 5.24 | -46.75 | -- | 79.78 | -- |
| Venus MedTech HangZhou Inc | 483.27m | -726.84m | 1.04bn | 605.00 | -- | 0.4434 | -- | 2.14 | -1.66 | -1.66 | 1.10 | 5.30 | 0.1218 | 0.9065 | 2.08 | 699,372.40 | -18.34 | -13.83 | -21.01 | -15.57 | 75.83 | 78.74 | -150.57 | -151.55 | 1.56 | -32.63 | 0.1928 | -- | -4.18 | 15.08 | -1.50 | -- | 11.12 | -- |
| Shanghai Bio-heart Biologicl Tech Co Ltd | 23.60m | -101.04m | 1.13bn | 70.00 | -- | 2.10 | -- | 47.97 | -0.4151 | -0.4151 | 0.0969 | 2.21 | 0.0251 | 0.8435 | 3.43 | 374,558.70 | -11.04 | -30.86 | -12.96 | -32.99 | 46.47 | -- | -439.71 | -- | 11.95 | -1.47 | 0.203 | -- | -- | -- | 50.00 | -- | 25.75 | -- |
| Beijing Airdoc Technology Co Ltd | 165.56m | -199.79m | 1.15bn | 193.00 | -- | 0.806 | -- | 6.93 | -1.95 | -1.95 | 1.62 | 13.90 | 0.1002 | 1.57 | 2.80 | 587,093.80 | -12.54 | -12.40 | -13.31 | -13.54 | 66.29 | 56.72 | -125.12 | -128.07 | 8.71 | -- | 0.0098 | -- | -23.34 | 38.74 | -92.75 | -- | 1.28 | -- |
| Cryofocus Medtech (Shanghai) Co Ltd | 96.33m | -85.98m | 1.35bn | 180.00 | -- | 20.32 | -- | 14.05 | -0.3596 | -0.3596 | 0.4029 | 0.2721 | 0.4945 | 1.12 | -- | 349,012.70 | -47.93 | -- | -72.64 | -- | 67.45 | -- | -96.93 | -- | 1.40 | -54.78 | 0.3918 | -- | 30.72 | -- | -7.06 | -- | -- | -- |
| Shanghai HeartCare Medcl Tech Corp Ltd | 378.85m | 48.00m | 1.57bn | 327.00 | 33.55 | 1.28 | 19.17 | 4.16 | 1.24 | 1.24 | 9.93 | 32.47 | 0.2736 | 0.7131 | 3.54 | 1,101,309.00 | 3.47 | -13.27 | 3.66 | -13.97 | 67.49 | 66.65 | 12.67 | -90.50 | 13.16 | -- | 0.0396 | -- | 19.61 | -- | 85.51 | -- | -24.35 | -- |
| Sisram Medical Ltd | 2.70bn | 160.77m | 1.70bn | 1.04k | 10.55 | 0.4658 | 5.18 | 0.6281 | 0.3432 | 0.3432 | 5.76 | 7.77 | 0.549 | 1.55 | 3.90 | 2,659,256.00 | 3.90 | 5.64 | 4.82 | 6.66 | 60.93 | 58.95 | 7.10 | 9.80 | 1.73 | -- | 0.0879 | 28.86 | -2.83 | 15.01 | -20.23 | 3.87 | 41.74 | 2.81 |
| Ethk Labs Inc | 3.48bn | 197.10m | 1.78bn | 877.00 | 9.21 | 0.459 | 7.33 | 0.5114 | 0.1205 | 0.1205 | 2.13 | 2.42 | 0.536 | 1.06 | 6.84 | 4,034,953.00 | 3.08 | 4.60 | 4.86 | 6.04 | 22.94 | 21.71 | 5.74 | 7.17 | 0.5095 | 5.12 | 0.3196 | -- | 2.40 | 6.27 | 9.35 | -1.08 | 10.78 | -- |
| PW Medtech Group Ltd | 955.63m | 165.78m | 1.90bn | 1.36k | 11.72 | 0.4371 | 5.23 | 1.99 | 0.1101 | 0.1101 | 0.6353 | 2.95 | 0.1603 | 2.91 | 11.47 | 675,355.30 | 3.52 | 7.71 | 4.42 | 8.74 | 52.62 | 56.56 | 21.96 | 75.91 | 9.12 | -- | 0.0042 | 8.38 | 13.90 | 16.25 | -1.57 | 12.96 | 8.75 | -- |
Data as of Mar 05 2026. Currency figures normalised to Sisram Medical Ltd's reporting currency: Hong Kong Dollar HKD
0.57%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Mellon Investments Corp.as of 06 Feb 2026 | 1.41m | 0.30% |
| HuaAn Fund Management Co., Ltd.as of 30 Jun 2025 | 521.20k | 0.11% |
| 1832 Asset Management LPas of 30 Jun 2025 | 487.36k | 0.10% |
| China Universal Asset Management Co., Ltd.as of 30 Jun 2025 | 212.00k | 0.05% |
| American Century Investment Management, Inc.as of 05 Feb 2026 | 19.20k | 0.00% |
More ▼
Data from 31 Dec 2025 - 31 Dec 2025Source: FactSet Research Systems Inc.
